Cite

    Mease, P. et al. (2009). Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor α antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study. Annals of the rheumatic diseases. 68 (8), pp. 1247-1254. [Online].